3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Non-small Cell Lung Cancer Metastatic
1
Interventions
pembrolizumab
28
Carboplatin
13
Nivolumab
12
Cisplatin
12
atezolizumab
10
Paclitaxel
10
venetoclax
9
Ipilimumab
9
Radiotherapy
8
Pemetrexed
8
Docetaxel
8
fludarabine
7
durvalumab
7
Specimen Handling
7
Gemcitabine
7
Cyclophosphamide
7
Bevacizumab
7
fludarabine phosphate
6
Practice Guidelines as Topic
6
Cetuximab
6
Biopsy
6
tislelizumab
5
enzalutamide
5
Trastuzumab
5
Standard of Care
5
Radiosurgery
5
Magnetic Resonance Spectroscopy
5
Dexamethasone
5
Cytarabine
5
tazemetostat
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
tusamitamab ravtansine
×
90 days
×
Clear all
NCT04154956
2026-05-18
CARMEN-LC03
Sanofi
Phase 3
Terminated
389 enrolled
16 charts